- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01204554
Microcirculation in Perforator Flaps. Enhancing Tissue Survival
September 16, 2010 updated by: Oslo University Hospital
The aim of the present study is to assess the microcirculatory changes in the distal part of the perforator flap using ICG fluorescence angiography.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Perforator flaps are increasingly used in reconstructive surgery both as pedicled and free flaps, mostly because of reduced donor site morbidity and superior aesthetic result.
However, the there is still much to learn about the hemodynamic changes within these flaps.The aim of the present study is to assess the microcirculatory changes in the distal part of the perforator flap using ICG fluorescence angiography.
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Haris Mesic, M.D
- Phone Number: 004722118080
- Email: haris.mesic@oslo-universitetssykehus.no
Study Locations
-
-
-
Oslo, Norway, 0304
- Recruiting
- Oslo University Hospital
-
Contact:
- Haris Mesic, M.D
- Phone Number: 004722118080
- Email: haris.mesic@oslo-universitetssykehus.no
-
Principal Investigator:
- Haris Mesic, M.D
-
Sub-Investigator:
- Ravi Bains, MD. PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients submitted to elective abdominoplasty
Exclusion Criteria:
- body mass index < 30 kg/m2
- morbidly obese
- patients with comorbidity such as diabetes
- vascular disease
- smokers
- patients < 18 years, and patients using anti-coagulant therapy
- pregnant
- severe hepatic insufficiency were excluded and a history of allergic reactions to ICG and iodide.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean pixel intensity using dynamic laser-induced-fluorescence-videoangiography
Time Frame: dec. 2008--des 2010
|
Perfusion measurements were conducted intraoperatively by assessing microcirculation using the technique of dynamic laser-induced-fluorescence-videoangiography (IC-VIEW, PULSION Medical Systems AG, Munich, Germany).
|
dec. 2008--des 2010
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2008
Primary Completion (Anticipated)
December 1, 2010
Study Completion (Anticipated)
December 1, 2010
Study Registration Dates
First Submitted
September 6, 2010
First Submitted That Met QC Criteria
September 16, 2010
First Posted (Estimate)
September 17, 2010
Study Record Updates
Last Update Posted (Estimate)
September 17, 2010
Last Update Submitted That Met QC Criteria
September 16, 2010
Last Verified
September 1, 2010
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 08/223b.2008/3837 (REK)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Microcirculation
-
Kartal Kosuyolu Yuksek Ihtisas Education and Research...Completed
-
University Hospital, AngersCompleted
-
National Taiwan University HospitalCompleted
-
National Taiwan University HospitalRecruitingKidney Transplant | MicrocirculationTaiwan
-
Maasstad HospitalCompletedMicrocirculationNetherlands
-
Afeka, The Tel-Aviv Academic College of EngineeringHebrew University of JerusalemCompleted
-
National Taiwan University HospitalCompleted
-
St. Antonius HospitalCompletedMicrocirculationNetherlands
-
University Hospital, AngersCompleted
-
Medical Centre LeeuwardenCompleted
Clinical Trials on Indocyanine green (ICG)
-
University of PennsylvaniaCompleted
-
Third Affiliated Hospital, Sun Yat-Sen UniversityUnknown
-
Fujian Medical UniversityNot yet recruitingEarly Gastric Cancer | Indocyanine Green | Lymph Node DissectionChina
-
Jules Bordet InstituteCompletedBreast CancerBelgium
-
Oxford University Hospitals NHS TrustTerminatedLymph Node Disease | Cancer of RectumUnited Kingdom
-
Oxford University Hospitals NHS TrustCompletedEsophageal Cancer | Chylothorax | Thoracic Duct Intra-Operative InjuryUnited Kingdom
-
Centre Hospitalier Universitaire Saint PierreUnknown
-
Centre Hospitalier Universitaire Saint PierreCompletedDetermination of the Occlusion Pressure in Lymphatic VesselsBelgium
-
Jules Bordet InstituteUnknown
-
Massachusetts General HospitalNational Cancer Institute (NCI); Dana-Farber Cancer Institute; Damon Runyon Cancer...CompletedColorectal Polyps | High Risk Polyposis Syndrome | Distal Colonic LesionsUnited States